In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Tzamal gets rights to sell Cardiome's Brinavess in Israel

Executive Summary

Cardiome Pharma Corp. (cardiovascular therapeutics) has granted Tzamal Medical Ltd. (provides pharmaceuticals and medical devices in Israel) exclusive Israeli marketing and distribution rights to Brinavess (vernakalant). The deal is for an initial three-year term and is renewable each year thereafter.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register